news
Stealth BioTherapeutics reported positive data from a pre-clinical study evaluating…
27 September 2021 | By Anna Begley (Drug Target Review)
Stealth BioTherapeutics reported positive data from a pre-clinical study evaluating SBT-272 in a murine model of Parkinson's disease.